Skip main navigation

Military Health System

Clear Your Cache

Health.mil has undergone a recent update. For the best user experience we recommend clearing your browser cache.

Patients Contribute to Shape Future Hearing Loss Treatment

Image of Barbara Kelly from the Hearing Loss Association of America hosting a meeting. Barbara Kelley, executive director of the Hearing Loss Association of America (left), kicks off the first-ever externally led patient-focused drug development meeting for hearing loss May 25, which heard from patients living with hearing loss, to aid in the Food and Drug Administration’s development of future hearing loss therapies. The Defense Health Agency’s Hearing Center of Excellence was among key collaborators involved in the event (Courtesy of HLAA).

The Defense Health Agency's Hearing Center of Excellence collaborated in a first-of-its-kind effort to aid in the development of future drug therapies and devices for patients with hearing loss. During the meeting authorized by the Food and Drug Administration, patients with hearing loss shared their testimonies.

The Hearing Loss Association of America (HLAA) hosted the externally led, patient-focused, drug development meeting for people living with sensorineural (inner ear damage) hearing loss May 25, with key FDA reviewers in attendance. The FDA establishes these types of meetings to help inform its decisions and supervision during drug development and review of marketing applications.

"This was an important opportunity for patients to tell the FDA about their symptoms, assessment of current treatments, experiences, and challenges they face living with hearing loss as a way to personally address their needs and conditions," said the HCE's division chief, Dr. Carlos Esquivel. "We were honored to collaborate as a patient organization with a dedicated interest in improving care and medications for those with hearing loss."

During the meeting, Dr. Gavin Imperato, with the FDA's Office of Tissues and Advanced Therapies, expressed enthusiasm at the opportunity to hear from patients as the FDA considers specific therapies for people with hearing loss.

The event included two panels of people with hearing loss and a group of patients, caregivers, and their families joining remotely, who shared their most burdensome symptoms, current treatments, and what they would like to see in future therapies.

According to the HLAA, the report Voice of the Patient will be published in the fall based on information from the meeting and comments from patients submitted to the organization through June 25.

The HCE's collaboration in the virtual meeting is a continuation of the center's ongoing engagement with the HLAA on several initiatives, dating back to 2014, according to Esquivel.

In other related efforts, HCE is leading the Pharmaceutical Interventions for Hearing Loss Working Group, which is examining drug development initiatives for service member and veteran hearing loss. The center also provides subject matter expert support to the Department of Defense's acquisition of the Pharmaceutical Intervention for Noise-induced Hearing Loss initiative.

You also may be interested in...

Policy
Sep 11, 2015

Instruction: #DODI 6490.13, Comprehensive Policy on Traumatic Brain Injury-Related Neurocognitive Assessments by the Military Services

This instruction establishes policy, assigns responsibilities, and prescribes standard elements, pursuant to section 722 of Public Law 111-383, requiring the implementation of a comprehensive neurocognitive assessment policy in the military services.

  • Identification #: DODI 6490.13
  • Type: Instruction
Policy
Oct 31, 2014

Memorandum: Pre-Deployment, Deployment, and Post-Deployment Training, Screening, and Monitoring Guidance for Department of Defense Personnel Deployed to Ebola Outbreak Areas

.PDF | 8.96 MB

Department of Defense personnel (Service members and civilian employees)deployed to Centers for Disease Control and Prevention defined Ebola outbreak areas will complete pre and post-deployment screening and training requirements outlined in this memorandum and supplemented by United States Africa Command (USAFRICOM) guidance.

  • Identification #: N/A
  • Type: Memorandum
Policy
Oct 20, 2014

Memorandum: #13-006, Addendum to Guidance on the Establishment of Department of Defense Standardization for Ordering and Procurement of Hearing Devices Prostheses 13-006

.PDF | 94.68 KB

This memorandum clarifies procedures relating to Health Affairs' "Guidance on the Establishment of Department of Defense Standardization for Ordering and Procurement of Hearing Devices/Prosthesis," dated August 15, 2013, which remains in effect.

  • Identification #: 13-006
  • Type: Memorandum
Policy
Apr 28, 2014

Instruction: #DODI 1010.10, Health Promotion and Disease Prevention

This instruction reissues DOD Directive 1010.10 (Reference (a)) as a DOD instruction (DoDI) in accordance with the authority in DODD 5124.02 (Reference (b)) to establish policy and assign responsibilities for health promotion and disease prevention in accordance with References (c) through (f).

  • Identification #: DODI 1010.10
  • Type: Instruction
Policy
Sep 18, 2012

Instruction: #DODI 6490.11, DOD Policy Guidance for Management of Mild Traumatic Brain Injury/Concussion in the Deployed Setting

This instruction establishes policy, assigns responsibilities, and provides procedures on the management of mild traumatic brain injury (mTBI), also known as concussion, in the deployed setting.

  • Identification #: DODI 6490.11
  • Type: Instruction
Policy
Apr 20, 2012

Memorandum: Guideline for Tuberculosis Screening and Testing

.PDF | 119.55 KB

Because accessions come from widely diverse geographic backgrounds, the Services should determine the need for tuberculin skin tests for accessions while Service members are at the training base, based on the needs of the specific accessions environment and operational mission requirements. DOD will implement targeted testing rather than universal ...

  • Identification #: N/A
  • Type: Memorandum
Policy
May 11, 2011

Instruction: DCoE Clinical Recommendations Post Injury NCAT

.PDF | 252.30 KB

In accordance with Section 1673 of the NDAA HR 4986, signed into law in January of 2008, the Secretary of Defense was instructed to establish a protocol for the pre-deployment assessment and documentation of the cognitive functioning of Service Members deployed outside the United States. In advance of definitive evidence of superiority for any single ...

  • Identification #: N/A
  • Type: Instruction
Skip subpage navigation
Refine your search
Last Updated: March 06, 2025
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Subscribe to updates from the MHS